# Investigating the Use of Genetics to Guide Pharmacologic Therapy for Hypertension

> **NCT02988245** · PHASE2 · UNKNOWN · sponsor: **Geneticure, LLC** · enrollment: 1000 (estimated)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Geneticure Panel for HTN therapy
- **DRUG:** JNC-8

## Key facts

- **NCT ID:** NCT02988245
- **Lead sponsor:** Geneticure, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-06
- **Primary completion:** 2023-05
- **Final completion:** 2023-12
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2022-02-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02988245

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02988245, "Investigating the Use of Genetics to Guide Pharmacologic Therapy for Hypertension". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02988245. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*